Macau starts using China’s Sinopharm’s Covid-19 vaccine despite a lack of Phase 3 clinical data

South China Morning Post published this video item, entitled “Macau starts using China’s Sinopharm’s Covid-19 vaccine despite a lack of Phase 3 clinical data” – below is their description.

Macau began vaccinating priority groups against Covid-19 on February 9, 2021. The city received 100,000 doses of the Sinopharm vaccine from Beijing on February 6. Despite a lack of Phase 3 clinical data from Sinopharm about its jabs, Macau has still approved the free and voluntary vaccination plan for its roughly 680,000 residents.

Support us:

https://subscribe.scmp.com

South China Morning Post YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

About This Source - South China Morning Post

The South China Morning Post (SCMP), with its Sunday edition, the Sunday Morning Post, is a Hong Kong-based English-language newspaper founded in 1903. It is Hong Kong’s newspaper of record, owned by Alibaba Group.

Recent from South China Morning Post:

  • Scenes from futuristic Mid-Autumn Festival celebrations in China #shorts
  • Asia’s ‘walled city’: why Hong Kong’s travel curbs hurt more than tourism
  • ‘We came to have fun’: Taliban fighters enjoy day out at Bamiyan national park
  • In This Story: Beijing

    Beijing, China’s sprawling capital, has history stretching back 3 millennia. Yet it’s known as much for modern architecture as its ancient sites such as the grand Forbidden City complex, the imperial palace during the Ming and Qing dynasties.

    2 Recent Items: Beijing

  • Scott Morrison meets Joe Biden in New York, flies to Washington | 7NEWS
  • CrossTalk | AUKUS vs China
  • In This Story: China

    China is the third largest country in the world by area and the largest country in the world by population. Properly known as the People’s Republic of China, the political territory of the country includes the former nations of Tibet and Hong Kong. The capital is Beijing.

    7 Recent Items: China

  • ‘The French were right’: Cheese is good for you • FRANCE 24 English
  • MOFA: Peace, development and win-win cooperation trend of times
  • Laughing Matters
  • Severe contagion risk from China’s Evergrande is low: Analyst
  • UN General Assembly: Biden says US not seeking ‘Cold War’ as he vows to lead • FRANCE 24 English
  • China’s Xi, like Biden hours earlier, turns to calm language • FRANCE 24 English
  • The Point: China’s space mission: what next?
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • Pfizer CEO on providing 500 million vaccines to low income countries
  • ‘The French were right’: Cheese is good for you • FRANCE 24 English
  • U.S. still struggling to address COVID-19 despite Biden’s promise to take country out of pandemic
  • Musicals Hamilton and Come From Away set to perform in front of Sydney crowds | 7NEWS
  • ‘Wide open’ border should concern every American: Fmr. ICE official
  • In This Story: Sinopharm

    China National Pharmaceutical Group Corp. known as Sinopharm is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine. Shanghai Shyndec Pharmaceutical and Beijing Tiantan Biological Products.

    2 Recent Items: Sinopharm

  • First batch of Chinese vaccines arrive in Kenya
  • China’s Sinopharm debuts new vaccines targeting COVID-19 variants
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.